Teva
Education Β· New Jersey, United States Β· 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Interpace Pkwy Fl 3, Parsippany, New...Phone Number
(800) 961-3604Website
www.tevagrants.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
4
2
2
1
2
About Teva
Teva Pharmaceuticals offers educational resources and grant opportunities aimed at healthcare professionals (HCPs) in various therapeutic areas, including Huntington's Disease, Tardive Dyskinesia, Schizophrenia, Bipolar Disorder, and Biosimilars. Their services focus on enhancing HCP knowledge and competence in diagnosing and managing these conditions, as well as understanding treatment options and patient care. The intended clients include neurologists, psychiatrists, nurses, nurse practitioners, physician assistants, social workers, and pharmacists, among others. Teva is dedicated to improving patient outcomes through comprehensive education and support for HCPs.Explore more
Popular SearchesTevaTardive DyskinesiaTeva Sales and Marketing IncSIC Code 82,829NAICS Code 61,611Show moreTeva Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Teva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Teva is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Teva
Teva, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Teva recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Teva has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Teva has new funding data
Click to see if Teva had a recent Job posting/layoffs
Product Launch: Get notified when Teva launches new products
Recommended Actions
Find VP level buyers at Teva
Find 2 more new buyers
Compare Similar Companies to Teva
Compare insights from companies similar to Teva, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Teva is experiencing very low activity levels compared to other companies in the Education sector.
What does this means?
Teva is drawing exceptional interest within the Education industry, suggesting notable developments or strong market momentum, learn more about Teva.
Teva Tech Stack
A closer look at the technologies used by Teva
Teva News & Media
Tardive Dyskinesia (TD) Market Research 2024: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Tardive Dyskinesia (TD) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been added to ResearchAndMarkets.com's offering. The MarketVue: Tardive Dyskinesia (TD) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market.Tardive Dyskinesia (TD) Treatment Drugs Market Report 2022: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2029 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Tardive Dyskinesia (TD) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering. Tardive dyskinesia (TD) is a rare neurological disorder due to long term use of antipsychotic medications which act on dopamine receptors. It is anticipated that the TD treatment drugs market will show significant market g
Read more news
Top Education Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Teva
Sign Up For FreeTo access detailed company insights
Teva Pharmaceuticals offers educational resources and grant opportunities aimed at healthcare professionals (HCPs) in various therapeutic areas, including Huntington's Disease, Tardive Dyskinesia, Schizophrenia, Bipolar Disorder, and Biosimilars. Their services focus on enhancing HCP knowledge and competence in diagnosing and managing these conditi... Read More
